You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 143 No. 7, July 2007 TABLE OF CONTENTS
  Archives
  •  Online Features
  Special Article
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Hematology/ Hematologic Malignancies
 •Leukemias/ Lymphomas
 •Neoplasms
 •Alert me on articles by topic

Cutaneous T-Cell Lymphoid Dyscrasia

A Unifying Term for Idiopathic Chronic Dermatoses With Persistent T-Cell Clones

Joan Guitart, MD; Cynthia Magro, MD

Arch Dermatol. 2007;143(7):921-932.

It often takes several years before the diagnosis of mycosis fungoides is clearly established. During this period preceding the diagnosis of cutaneous T-cell lymphoma (CTCL), some patients experience a variety of distinct skin conditions of ambiguous origin. With refinement in the methods of T-cell clonal detection in skin biopsy specimens, we can now establish that many of these preceding entities are characterized by a T-cell clone. Therefore, we studied the association of these clonal conditions with CTCL. We identified 8 distinct clinicopathological conditions characterized by the frequent detection of T-cell clonality, a chronic course often recalcitrant to topical therapy, lack of a known triggering event, and lack of morphologic evidence of a T-cell lymphoma with potential for progression to CTCL. We propose the term cutaneous T-cell lymphoid dyscrasias to unify these entities. Defining the preceding stages of CTCL is important to properly categorize these conditions and to help us understand and redefine the evolution of idiopathic clonal dermatoses and their potential for lymphoma progression.


Author Affiliations: Department of Dermatology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois (Dr Guitart); and Department of Pathology, Cornell University, New York, New York (Dr Magro).







HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2007 American Medical Association. All Rights Reserved.